AnalystsCatherine RamseyCatherine Ramsey's Stock Forecasts
AnalystsCatherine Ramsey
Sectors:
Analyst Ranking
Top 24%
#1151 out of 4862 analysts
Average Return
+1.99%
Win Rate
32%12 out of 37
Risk vs Reward
Poor
Good
Catherine Ramsey's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Twist Bioscience CorpTWST | +221.87% | $13.40 | $43.13 | 2023-05-07 - 2024-05-07 | Buy |
Castle Biosciences IncCSTL | +101.72% | $11.66 | $23.52 | 2023-06-04 - 2024-06-04 | Buy |
Natera IncNTRA | +86.58% | $51.21 | $95.55 | 2023-05-09 - 2024-05-09 | Buy |
Exact Sciences CorpEXAS | +78.88% | $47.59 | $85.13 | 2022-08-02 - 2023-08-02 | Buy |
Twist Bioscience CorpTWST | +53.43% | $23.73 | $36.41 | 2023-02-05 - 2024-02-05 | Buy |
Catherine Ramsey Analyst Color
Get additional color on Catherine Ramsey's coverage of popular stocks
Catherine Ramsey's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revvity IncRVTY | 4 | Buy | $127.00 | +41.47% | Maintains | a day ago |
Waters CorpWAT | 8 | Buy | $407.00 | +28.70% | Upgrades | a month ago |
Illumina IncILMN | 5 | Hold | $90.00 | +25.00% | Maintains | 2 months ago |
Natera IncNTRA | 6 | Buy | $188.00 | +32.18% | Maintains | 2 months ago |
Castle Biosciences IncCSTL | 8 | Buy | $37.00 | +75.02% | Maintains | 2 months ago |
Twist Bioscience CorpTWST | 6 | Buy | $54.00 | +56.25% | Maintains | 3 months ago |
Nanostring Technologies IncNSTGQ | 3 | Hold | $0.75 | N/A | Downgrades | a year ago |
Thermo Fisher Scientific IncTMO | 2 | Buy | $665.00 | N/A | Maintains | 2 years ago |
Agilent Technologies IncA | 5 | Buy | $160.00 | N/A | Maintains | 3 years ago |
Exact Sciences CorpEXAS | 1 | Buy | $75.00 | N/A | Maintains | 3 years ago |
Centogene NvCNTGF | 1 | Buy | $20.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.